Company intelligence / Profile preview

Balmoral Financial Group

London, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

No evidence exists that “Balmoral Financial Group” is or was an operating entity in life sciences/biotech/pharma/healthcare as a developer, manufacturer, or owner of clinical programs. All evidence indicates that similarly named entities are generalist or sector-diversified private equity or investment firms, with some openness to healthcare investment but not operating as healthcare/life science companies themselves. The only registered “Balmoral Financial” entity (“BALMORAL FINANCIAL LIMITED”) is dissolved and was a finance house, not a health company.

Industry: Investors

Beyond the preview

Go deeper on Balmoral Financial Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Balmoral Financial Group.

Explore the full profile